Tomi is passionate about building relationships with clients and helping them attain their business goals and objectives. With a background in law, international development and human rights, she is keen on bringing about a positive difference around healthcare inequities and shaping health outcomes for all groups.
Tomi enjoys spending good quality time with friends and family. She also is passionate about travel and learning different cultures and histories along the way.
15.11.2022 | Article
MSLs are facing an issue of having increasingly limited access to HCPs
By Tomi Shobande
14.11.2022 | Article
HCP's shared the news on product approvals for issues like obesity, multiple myeloma, etc.
By Paul Cranston and Tomi Shobande
05.07.2022 | Article
HCPs also held around the approval of treatments for monkeypox
By Paul Cranston and Tomi Shobande
02.07.2022 | Article
with notable excitement being found for the FDA’s approval of Novartis’ 5th agnostic...
By Paul Cranston and Tomi Shobande
06.06.2022 | Article
Over the last month, HCPs discussed product approvals for the treatment of a variety...
By Paul Cranston and Tomi Shobande
19.05.2022 | Article
Discover which new drug approvals HCPs are talking about
By Paul Cranston and Tomi Shobande
13.05.2022 | Article
The healthcare industry witnessed a paradigm shift since the COVID-19 pandemic began...
By Tomi Shobande
12.04.2022 | Article
HCPs discuss approvals for several cancer treatments and a fourth dose of COVID-19 vaccines
By Paul Cranston and Tomi Shobande
11.03.2022 | Article
HCPs discuss approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk
By Paul Cranston and Tomi Shobande
09.02.2022 | Article
HCPs also shared the news of approvals of treatments for NSCLC
By Paul Cranston and Tomi Shobande
10.01.2022 | Article
Discover which new drug approvals dominated HCPs conversations pre-Christmas...
By Paul Cranston and Tomi Shobande
01.12.2021 | Article
Discover which new drug approvals HCPs are talking about
By Paul Cranston and Tomi Shobande
